April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Colorectal tumor biomarker may predict immunotherapy effectiveness
May 2, 2019 | Zen Vuong
The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.
New Immunotherapy for Colon Cancer Answers a Patient's Prayer
December 24, 2018 | Maxine Nunes
After a CAT scan found a suspicious spot, a colonoscopy showed that Quiana Godinez had colon cancer. Godinez was put on the breakthrough immunotherapy drug Keytruda (pembrolizumab), which had just received FDA approval for certain types of cancers, including hers.
New colorectal screening guidelines: What they mean for you
August 20, 2018 | Molly Peck
The American Cancer Society has changed the recommended age to start colorectal screening to 45, following a sustained increase in colorectal cancer in adults under 50.
Groundbreaking Heated Chemotherapy Treatment Gives Patient Renewed Hope
June 28, 2018 | Wayne Lewis
Suffering from abdominal pain that had grown severe over the course of a few days, Christopher Haskell visited his physician, a visit that ended up resulting in the discovery of a tumor growing in his appendix and colon. His City of Hope physician recommended an approach called HIPEC, short for “hyperthermic intraperitoneal chemotherapy.”
7 Things You Need to Know About Men's Cancers (Infographic)
June 19, 2017 | City of Hope
About 40 percent of men will receive a cancer diagnosis at some point in their lives. That’s a sobering statistic, and one that we highlight every June during Men’s Health Month. With that in mind, here is our infographic with everything men need to know about cancer.
City of Hope Physicians and Scientists Present Trailblazing Research at Annual ASCO Meeting
June 2, 2017 | Letisia Marquez
City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.
Make March the Month You "Screen to Save"
March 2, 2017 | City of Hope
Colorectal cancer is the fourth most common type of cancer and the second deadliest. Despite those grim statistics, in most states less than 20 percent of racial and ethnic minorities have been screened for CRC within the past year. For physicians and scientists at City of Hope, that number is far too low.